Cornerstone Advisors (Washington)’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-124	Closed	-$7K	–	907
2016 Q1	$7K	Hold	124	–	–	0.01%	515
2015 Q4	$14K	Buy	+124	New	+$13.7K	0.02%	390

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Cornerstone Advisors (Washington)'s ANAC Position: Q2 2016 in Review

Cornerstone Advisors (Washington) sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 124 shares — an estimated $7K sold.

Cornerstone Advisors (Washington) first reported a position in ANAC in Q4 2015 and held it in 2 quarters. The position peaked at $14K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Cornerstone Advisors (Washington) reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Cornerstone Advisors (Washington) sold 124 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $7K.
Cornerstone Advisors (Washington) first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2015 and held it in 2 quarters.
Cornerstone Advisors (Washington)'s ANACOR PHARMACEUTICALS INC COM position peaked at $14K in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q2 2016, filed 25 Jul 2016.